Bioceltix S.A.
BCX | WAR
Overview
Corporate Details
- ISIN(s):
- PLBCLTX00019 (+1 more)
- LEI:
- 259400QZD5JYK8SLZU51
- Country:
- Poland
- Address:
- Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław
- Website:
- https://bioceltix.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Bioceltix is a team of experts working on innovative therapies for veterinary use. We work on biopharmaceuticals that harness the immunomodulatory properties of mesenchymal stem cells. We develop them following the highest quality and safety standards. We possess cutting-edge research and production facilities, cooperate with ambitious scientists, and operate under a well-developed business model. Our goal is to market new, effective solutions in the field of veterinary medicine. The safety and efficacy of Bioceltix products will also be verified through field clinical trials carried out in accordance with Good Clinical Practice (GCP). The independent trials will be conducted in leading veterinary centres, under the supervision of the Polish Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL).
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-05-07 18:29 |
Declaration of Voting Results & Voting Rights Announcements
Informacja o liczbie akcji i głosów
|
Polish | 74.3 KB | |
| 2024-05-07 18:29 |
General Meeting Notice
Klauzula informacyjna o przetwarzaniu danych osobowych
|
Polish | 174.2 KB | |
| 2024-05-07 18:29 |
Proxy Solicitation & Information Statements
Formularz głosowania przez pełnomocnika
|
Polish | 160.9 KB | |
| 2024-05-07 18:29 |
Registration Form
Formularze pełnomocnictwa
|
Polish | 115.1 KB | |
| 2024-05-07 18:29 |
Share Issue/Capital Change
Zestawienie zmian statutu
|
Polish | 86.8 KB | |
| 2024-05-07 18:29 |
Share Issue/Capital Change
Opinia Zarządu
|
Polish | 73.1 KB | |
| 2024-05-07 18:29 |
AGM Report
Projekty uchwał wraz z uzasadnieniem
|
Polish | 148.9 KB | |
| 2024-05-07 18:29 |
General Meeting Notice
Ogłoszenie o zwołaniu NWZ
|
Polish | 145.2 KB | |
| 2024-05-07 18:29 |
General Meeting Notice
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
|
Polish | 2.1 KB | |
| 2024-05-07 17:38 |
Share Issue/Capital Change
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
|
Polish | 5.4 KB | |
| 2024-04-26 17:12 |
Annual Audited Financial Statements
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
|
Polish | 10.3 KB | |
| 2024-04-26 17:12 |
Annual Audited Financial Statements
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
|
Polish | 2.9 MB | |
| 2024-04-26 17:12 |
Annual Audited Financial Statements
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
|
Polish | 20.9 KB | |
| 2024-04-26 17:12 |
Annual Report
Raport okresowy roczny Bioceltix S.A. za rok 2023
|
Polish | 17.3 MB | |
| 2024-04-26 17:12 |
Annual Report
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
|
Polish | 20.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |